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Hyponatremia  is  the electrolyte  abnormality  most  often
encountered  in patients  admitted  for  heart  failure  (HF).1--3
Its  prevalence  ranges  between  18  and  30%,4--8 although
it  is lower  in stable  HF  outpatients  (10-17%).9--12 It  also
varies  with  the severity  and  duration  of  HF, the criteria
used  to  define  it,  medication  prescribed  and  drug  doses,
particularly  of  diuretics.  Most studies  define  hyponatremia
as  Na  <135  mEq/l,  although  some use  quartiles,  and  a
linear  relation  has  been  observed  between  risk  of  short-
and  long-term  total  mortality  and  in-hospital  cardiovascu-
lar  morbidity  and mortality  and sodium  <140  mEq/l.  Other
studies  have  demonstrated  a  U-curve  for values  between  140
and  145  mEq/l.4--12 The  value of natremia  as  a  risk  indicator
is  thus  evident  even  for values  considered  normal;  for  every
3  mEq/l  fall  in  blood  sodium  the  risk  of in-hospital  mor-
tality  rises  by 19.5%  in HF  with  systolic  dysfunction  and  by
8.6%  in  HF  with  preserved  systolic  function,  and  mortality
60-90  days  after  discharge  rises  by 10-18%.4,5 Pathophys-
iologically,  hyponatremia  is  multifactorial,  usually  due  to
hypervolemia  related  to  hyperactivity  of  the sympathetic
and  rein-angiontensin-aldosterone  systems  and  their effects
on  the  kidneys.  This  hyperactivity  is  in turn  secondary  to
reduced  cardiac  output  and consequent  reduced  stimulation
of  aortic  and  carotid  baroreceptors,  which  also  induces  an
excessive  increase  in non-osmotic  secretion  of vasopressin
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and  hence  fluid  retention.1--3 However,  diuretic  therapy  can
transform  this  to  normovolemia  or  even  hypovolemia.1--3
Recent  reports  suggest  that  chronic  inflammation  mediated
by  interleukin-6  may  play  a  part  in  this  increased  vasopressin
secretion.13
The  relationship  between  blood  pressure  (BP)  and HF,
which  may  appear  a  simple  one  due  to  the known  importance
of  high  BP in the etiopathogenesis  of HF,  becomes  more  com-
plex  in  light of the results  of  various  studies  that report
worse  prognosis  in  HF  patients  with  lower  office  systolic  BP,
particularly  below 120 mmHg,  on  admission,  at discharge  or
even  as  outpatients,  especially  if they  have  reduced  ejection
fraction  (EF).14--17 A meta-analysis  of  10  studies  including
over  8000  patients  with  stable  chronic  HF  showed  a  reduc-
tion  in mortality  of  13%  for  every  10  mmHg  higher  systolic  BP
on  admission.17 However,  some  authors  describe  a  U-shaped
curve  for  long-term  mortality  with  values  between  120 and
139  mmHg,  with  slight  differences  between  reduced  and
preserved  EF.15
Most studies  on  the  prognostic  value  of  blood  sodium
levels  in HF have shown  that  hyponatremia  is  associated
with  significantly  lower  office  BP,  which  is  also  indepen-
dently  associated  with  higher  risk.4--12 The  few  studies  on
the  prognostic  value  of  ambulatory  BP  monitoring  (ABPM)  in
HF  show that  non-dipper  profiles  (inverted  dipper  or  riser)
are  more  common  in these patients,  possibly  related  to
increased  sympathetic  activity,  and  that  these  profiles  are
significantly  associated  with  worse  prognosis  than  for  a  dip-
per  profile,18--20 as  has been  shown  in  hypertensive  patients
and  in population-based  studies.21,22 However,  to  the  best  of
my  knowledge  no  studies  have  set  out to  relate  natremia  lev-
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els  with  BP values  recorded  by  ABPM  or  with  possible  changes
in  circadian  patterns.
The  study  by Arévalo-Lorido  et  al.23 published  in  this  issue
of  the  Journal  sets  out  to  analyze  precisely  this relation-
ship  in  175  patients  with  stable  HF,  mostly  of  hypertensive
etiology,  assessed  by  ABPM.  The  authors  found  a  significant
correlation  between  serum  sodium  levels  and systolic  BP
by  ABPM  in  multivariate  analysis,  as  well  as  a  low preva-
lence  of  dipper  pattern  (20.5%),  as  has been  reported  both
in  patients  hospitalized  for  acute  HF  and  in those with  stable
chronic  HF.18--20 Furthermore,  although  they  did  not  specif-
ically  examine  the subgroup  with  Na  <135  mEq/l,  the  usual
definition  of  hyponatremia,  they  found that  in the lowest
quartile  (133-139  mEq/l),  both  mean  24-hour  and mean  day-
time  systolic  BP levels  by  ABPM  were  consistently  lower  than
in  the  other  quartiles.  It should  be  noted  that  there  were
no  significant  differences  in  drugs  prescribed  in  the differ-
ent  quartiles,  including  diuretics.  There  was  also  a  lower
prevalence  of dipper  pattern  and  a  higher  proportion  of  ris-
ers  in  the  lowest  quartile.  Although,  as  pointed  out  above,
non-dipper  profiles  are common  in HF with  either  reduced
or  preserved  EF,  the  riser  pattern  has  recently  been  par-
ticularly  strongly  associated  with  HF with  preserved  EF  and
with  increased  risk.19,20 In the present  study,  most  patients
in  all  quartiles  of serum  sodium  levels  had preserved  EF,
which  may  explain  the high  proportion  of risers  (38%),  but
this  contrasts  with  the  lower  proportion  seen in hypertension
(5-19%).
The  authors  point  out  certain  limitations  of  their  study,
including  the fact that  they  were  unable  to  form  a  true
hyponatremic  group,  i.e.  with  sodium  level  <135  mEq/l
(although  several  studies  have  shown  increased  risk  with
levels  below  140 mEq/l5,9,10), and  that  they  could  not  ana-
lyze  HF  with  reduced  and  preserved  EF separately,  due  to
the  preponderance  of  the latter,  which  could  have  further
clarified  some  of  the inter-relationships  that  have recently
been  reported,  especially  the increased  risk  seen in  HF
patients  with  riser  profile  and with  preserved  (but  not
reduced)  EF.20 Nevertheless,  we  consider  their  work  to  be
original  and  of  considerable  interest,  as  it confirms  the pre-
viously  described  association  between  low  sodium  levels
and  lower  office  BP in stable  HF  patients,  only this  time
with  24-hour  ABPM,  with  its  added  diagnostic  and  prog-
nostic  value.  Furthermore,  they  raise  the possibility  that
the  changes  in circadian  profile  found  mostly  in the  lowest
serum  sodium  quartile,  particularly  the  lower  prevalence
of  night-time  dipping  and the  significantly  higher  propor-
tion  of  riser  profile,  may  improve  risk  stratification,  higher
risk  being  associated  with  lower  sodium  levels,  as  described
in  studies  of both  hospitalized4--8 and  outpatient9--12 HF
populations.  The  study  may  also  contribute  toward  a  bet-
ter  understanding  of  the  pathophysiology  involved,  with
specific  serum  sodium  levels  being  used  as  markers  or
risk  factors  for overall  mortality  and  cardiovascular  mor-
bidity  and  mortality  in  HF,  and possibly  as  therapeutic
targets.
Conflicts of  interest
The  author  has  no  conflicts  of  interest  to declare.
References
1. Sica DA. Hyponatremia and heart failure -- pathophysiology and
implications. Congest Heart Fail. 2005;11:274--7.
2. Farmakis D, Filippatos G,  Parissis J. Hyponatremia in heart fail-
ure. Heart Fail Rev. 2009;14:59--63.
3. Filippatos TD, Elisaf MS. Hyponatremia in patients with heart
failure. World J Cardiol. 2013;5:317--28.
4. Klein L,  O’Connor CM,  Leimberger J,  et  al. Lower serum sodium
is associated with increased short-term mortality in hospital-
ized patients with worsening heart failure: results from the
Outcomes of a Prospective Trial of Intravenous Milrinone for
Exacerbations of  Chronic Heart Failure (OPTIME-CHF) study. Cir-
culation. 2005;111:2454--60.
5. Gheorghiade M, Abraham WT, Albert NM, et al. Relationship
between admission serum sodium concentration and clinical
outcomes in patients hospitalized for heart failure: an anal-
ysis from the OPTIMIZE-HF registry. Eur Heart J. 2007;28:
980--8.
6. Gheorghiade M, Rossi JS, Cotts W, et  al. Characterization and
prognostic value of persistent hyponatremia in patients with
severe heart failure in the  ESCAPE trial. Arch Intern Med.
2007;167:1998--2005.
7. Soto NS, Gheorghiade M, Kajimoto K, et al. Hyponatremia
and in-hospital mortality in patients admitted for heart fail-
ure (from the ATTEND registry). Am J Cardiol. 2013;111:
1019--25.
8. Lorido JCA, Gómez JC,  Formiga F,  et al. Hyponatremia as pre-
dictor of worse outcome in real world patients admitted with
acute heart failure. Cardiol J. 2013;20:506--12.
9. Balling L,  Schon M, Videboek L,  et al. Prevalence and prognostic
significance of  hyponatremia in outpatients with chronic heart
failure. Eur J  Heart Fail. 2011;13:968--73.
10. Rusinaru D, Tribouillory C, Berry C, et al. Relationship of serum
sodium concentration to mortality in a wide spectrum of heart
failure patients with preserved and with reduced ejection frac-
tion: an individual patient data meta-analysis. Eur Heart Fail.
2012;14:1139--46.
11. Bavishi C, Ather S, Bambhroliya A, et al. Prognostic significance
of hyponatremia among ambulatory patients with heart failure
and  preserved and reduced ejection fractions. Am J Cardiol.
2014;13:1834--8.
12. Deubner N,  Berliner D,  Frey A, et  al. Dysnatremia in heart fail-
ure. Eur J  Heart Fail. 2012;14:1147--54.
13. Swart RM, Hoorn EJ, Betjes MG, et al. Hyponatremia and inflam-
mation: the emerging role of  interleukin-6 in osmoregulation.
Nephron Physiol. 2011;118:45--51.
14. Gheorghiade M,  Abraham WT, Albert NM, et  al. Systolic
blood pressure at admission, clinical characteristics and out-
comes in patients hospitalized with acute heart failure. JAMA.
2006;296:2217--26.
15. Lee DS, Ghosh N, Floras JS, et al. Association of blood pressure
at hospital discharge with mortality in patients diagnosed with
heart failure. Circ Heart Fail. 2009;2:616--23.
16. Nún˜ez J, Nún˜ez E, Fonarow GC, et  al. Differential prognostic
effect of  systolic blood pressure on  mortality according to left-
ventricular function in patients with acute heart failure. Eur J
Heart Fail. 2010;12:38--44.
17. Raphael CE, Whinnett ZI, Davies JE, et al. Quantifying the para-
doxical effect of  higher systolic blood pressure on mortality in
chronic heart failure. Heart. 2009;95:56--62.
18. Shin J, Kline S, Moore M,  et al. Association of diurnal blood
pressure pattern with risk of  hospitalization or death in men
with heart failure. J Cardiac Fail. 2007;13:656--62.
19. Komori T, Eguchi K, Saito T, et al. Riser pattern: another deter-
minant of heart failure with preserved ejection fraction. J  Clin
Hypertens. 2016;18:994--9.
Serum  sodium  levels  and  ambulatory  blood  pressure  monitoring  in  heart  failure  523
20. Komori T, Eguchi K,  Saito T, et  al.  Riser pattern is a  novel predic-
tion of adverse events in heart failure patients with preserved
ejection fraction. Circ J. 2017;81:220--6.
21. Fagard RH, Thijs L,  Staessen JA, et  al. Night-day blood
pressure ratio and dipping pattern as predictors of  death
and cardiovascular events in hypertension. J Hum Hypertens.
2009;23:645--53.
22. Salles GF, Reboldi G,  Fagard RH, et  al. Prognostic effect of
the nocturnal blood pressure fall in hypertensive patients
-- the Ambulatory Blood Pressure Collaboration in patients
with Hypertension (ABC-H) meta-analysis. Hypertension.
2016;67:693--700.
23. Arévalo-Lorido JC, Carretero-Gómez J, Espinosa LM, et  al.
Ambulatory blood pressure monitoring in heart failure and
serum sodium levels. Rev Port Cardiol. 2017;36:513--20.
